Welcome to AmPolGen Pharmaceuticals, LLC.
 

AmPolGen Pharmaceuticals, LLC. is in engaged in research and development of gene targeted therapies. AmPolGen's current efforts focus on Sodium Phenylbutyrate (PB) and related compounds. Ampolgen was established in December of 2003, in order to engage in research, manufacturing, marketing, promotion, and sale of certain compounds which are known to effect expression of genes. more....